# PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure

> **NCT07409259** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 20 (estimated)

## Conditions studied

- Acute-on-Chronic Liver Failure (ACLF)

## Interventions

- **BIOLOGICAL:** exosome injection
- **COMBINATION_PRODUCT:** standard comprehensive internal medical treatment,

## Key facts

- **NCT ID:** NCT07409259
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07409259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07409259, "PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07409259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*